Damora Therapeutics, Inc. (DMRA): 10-Q filed Nov 4, 2026

Form type

10-Q

Filing date

Nov 4, 2026

Accession number

0001193125-26-447162

Filer

Damora Therapeutics, Inc. (CIK 1800315)